CommercialCoverageMedium impact
08.01.75d, Margetuximab-cmkb (Margenza)
Independence Blue Cross·Oncology, Hematology·Pharmacy
Effective date
May 28, 2025
We identified it
Jun 19, 2026
Summary
Independence Blue Cross has reissued their medical policy for Margetuximab-cmkb (Margenza), an oncology medication, with an effective date of May 28, 2025. This is a pharmacy policy update that will affect billing and coverage for this specific cancer treatment drug.
Action Required
Before May 28, 2025: Billing team should review the updated Margetuximab-cmkb (Margenza) policy at the provided URL to understand any changes in coverage criteria, prior authorization requirements, or billing guidelines for this oncology medication. Update any relevant protocols for prescribing and billing this drug.